FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

446321003: Denosumab (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2011. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2879834015 Denosumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2881966015 Denosumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
52521000195111 denosumab it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
804441000172111 dénosumab fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
66871000195118 Denosumab de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Denosumab (substance) Is a agent d'anticorps monoclonal false Inferred relationship Some
Denosumab (substance) Is a Monoclonal antibody true Inferred relationship Some
Denosumab (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Receptor activator of nuclear factor kappa-B ligand inhibitor (disposition) true Inferred relationship Some
Denosumab (substance) Is a Substance with receptor activator of nuclear factor kappa-B ligand inhibitor mechanism of action (substance) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Denosumab 60 mg/mL solution for injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Denosumab (substance) Inferred relationship Some
Product containing denosumab (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Denosumab (substance) Inferred relationship Some 1
Denosumab therapy Direct substance True Denosumab (substance) Inferred relationship Some 2
Allergy to denosumab (finding) Causative agent (attribute) True Denosumab (substance) Inferred relationship Some 1
Product containing only denosumab (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Denosumab (substance) Inferred relationship Some 1
Denosumab 60 mg/mL solution for injection This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Denosumab (substance) Inferred relationship Some 1
Denosumab 60 mg/mL solution for injection The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Denosumab (substance) Inferred relationship Some 1
Denosumab-containing product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Denosumab (substance) Inferred relationship Some 1
Denosumab only product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Denosumab (substance) Inferred relationship Some 1
Denosumab 70 mg/mL solution for injection The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Denosumab (substance) Inferred relationship Some 1
Denosumab 70 mg/mL solution for injection This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Denosumab (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start